Maximo F Nougues is Chief Financial Officer of PUMA BIOTECHNOLOGY, INC.. Currently has a direct ownership of 162,522 shares of PBYI, which is worth approximately $508,693. The most recent transaction as insider was on Jul 17, 2024, when has been sold 4,156 shares (Common Stock) at a price of $3.7 per share, resulting in proceeds of $15,377. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 163K
0% 3M change
12.59% 12M change
Total Value Held $508,693

MAXIMO F NOUGUES Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 17 2024
SELL
Open market or private sale
$15,377 $3.7 p/Share
4,156 Reduced 2.49%
162,522 Common Stock
Jul 02 2024
SELL
Open market or private sale
$17,314 $3.27 p/Share
5,295 Reduced 3.08%
166,678 Common Stock
Feb 12 2024
BUY
Grant, award, or other acquisition
-
43,307 Added 20.12%
171,973 Common Stock
Jan 03 2024
SELL
Open market or private sale
$70,412 $4.49 p/Share
15,682 Reduced 10.86%
128,666 Common Stock
Jul 03 2023
SELL
Open market or private sale
$48,590 $3.31 p/Share
14,680 Reduced 9.23%
144,348 Common Stock
Feb 10 2023
BUY
Grant, award, or other acquisition
-
58,601 Added 26.93%
159,028 Common Stock
Jan 03 2023
SELL
Open market or private sale
$43,885 $4.18 p/Share
10,499 Reduced 9.46%
100,427 Common Stock
Dec 02 2022
SELL
Open market or private sale
$715 $4.5 p/Share
159 Reduced 0.14%
110,926 Common Stock
Nov 02 2022
SELL
Open market or private sale
$366 $2.25 p/Share
163 Reduced 0.15%
111,085 Common Stock
Oct 03 2022
SELL
Open market or private sale
$386 $2.34 p/Share
165 Reduced 0.15%
111,248 Common Stock
Sep 02 2022
SELL
Open market or private sale
$425 $2.59 p/Share
164 Reduced 0.15%
111,413 Common Stock
Aug 02 2022
SELL
Open market or private sale
$465 $2.89 p/Share
161 Reduced 0.14%
111,577 Common Stock
Jul 05 2022
SELL
Open market or private sale
$15,346 $2.63 p/Share
5,835 Reduced 8.28%
64,625 Common Stock
Jun 02 2022
SELL
Open market or private sale
$311 $1.92 p/Share
162 Reduced 0.13%
121,066 Common Stock
May 03 2022
SELL
Open market or private sale
$386 $2.34 p/Share
165 Reduced 0.14%
121,228 Common Stock
Apr 04 2022
SELL
Open market or private sale
$634 $3.08 p/Share
206 Reduced 0.17%
121,393 Common Stock
Mar 03 2022
BUY
Grant, award, or other acquisition
-
62,176 Added 33.83%
121,599 Common Stock
Mar 02 2022
SELL
Open market or private sale
$382 $2.26 p/Share
169 Reduced 0.28%
59,423 Common Stock
Feb 02 2022
SELL
Open market or private sale
$494 $2.48 p/Share
199 Reduced 0.33%
59,592 Common Stock
Jan 03 2022
SELL
Open market or private sale
$23,874 $3.19 p/Share
7,484 Reduced 11.12%
59,791 Common Stock
Dec 02 2021
SELL
Open market or private sale
$478 $2.95 p/Share
162 Reduced 0.24%
67,275 Common Stock
Nov 02 2021
SELL
Open market or private sale
$885 $5.67 p/Share
156 Reduced 0.23%
67,437 Common Stock
Oct 04 2021
SELL
Open market or private sale
$998 $6.2 p/Share
161 Reduced 0.24%
67,593 Common Stock
Sep 02 2021
SELL
Open market or private sale
$1,164 $7.51 p/Share
155 Reduced 0.23%
67,754 Common Stock
Aug 02 2021
SELL
Open market or private sale
$1,161 $7.54 p/Share
154 Reduced 0.23%
67,909 Common Stock
MFN

Maximo F Nougues

Chief Financial Officer
Los Angeles, CA

Track Institutional and Insider Activities on PBYI

Follow PUMA BIOTECHNOLOGY, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PBYI shares.

Notify only if

Insider Trading

Get notified when an Puma Biotechnology, Inc. insider buys or sells PBYI shares.

Notify only if

News

Receive news related to PUMA BIOTECHNOLOGY, INC.

Track Activities on PBYI